A Global Perspective on Clinical Laboratory Leadership and Management During a Pandemic
|
By Kimberly Scott (AACC) Posted on 12 Jul 2022 |

Image: A Global Perspective on Clinical Laboratory Leadership and Management During a Pandemic (Photo courtesy of aacc.org)
During the COVID-19 pandemic, clinical laboratories across the world have been challenged in many ways, including having to contend with clinically significant variability in test results that are amplified at the international level.
Laboratory medicine professionals have responded to the challenge with initiatives to harmonize reference intervals, action limits, critical result reporting, continuous quality improvement, inventory management, resource allocation, cost of ownership, deployment of automation, and implementation of digital technology transformation systems.
How labs are dealing with these challenges will be discussed during a Roundtable Session, Clinical Laboratory Leadership and Management During a Pandemic: A Global Perspective, on Tuesday, July 26 at the 2022 AACC Annual Scientific Meeting in Chicago. Barnali Das, MD, DNB, PGDHHM, a consultant in laboratory medicine for Kokilaben Dhirubhai Ambani Hospital in Mumbai, India, will explore effective leadership strategies for process re-engineering, time management, resource and personnel management, team development, strategic planning, global harmonization, and cost of ownership.
“In this pandemic, processes need to be streamlined in laboratory medicine to ensure provision of reliable and timely test results and appropriate alliance with brain-to-brain loops, thus enhancing quality of care and patient safety,” Das said, who is also chair of AACC’s India Local Section. “By adopting strategic thinking, embracing innovation, and investing in cross-training and safety measures, laboratory staff can contribute to patient satisfaction, reduced staff turnover, and improved laboratory performance. This contributes to successful operations and, at the same time, improves staff training, job satisfaction, and empowerment.”
Among the topics that will be covered in the session:
Harmonization and standardization of laboratory assays.
“What is considered the normal and acceptable range of different laboratory test results in a particular population have long been debated by experts, largely because levels of markers can change in relation to other biochemicals, biomolecules, and hormones, which themselves vary with race, age, different physiological conditions, and other illnesses and interfering substances,” Das said, who is also executive member of scientific division of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and has worked with different standardization committees of IFCC.
Total laboratory automation and artificial intelligence in routine laboratory testing.
Rapid changes in the diagnostic sector, coupled with advances in technology, have stimulated new approaches for laboratory automation and artificial intelligence in routine laboratory process flows. How are clinical laboratories across the globe employing these technologies to improve operations?
Leadership skills for effective laboratory management.
From team development to stress management to communication, laboratory leaders use various tools to ensure their teams are operating effectively. What are some successful techniques clinical laboratories in different parts of the world employ?
Cost of ownership.
Proper management of both direct and indirect costs is crucial to making operational improvements. Das will explore ways laboratorians can have a dramatic impact on performance using value stream maps.
She will also present results of a survey sent to lab leaders across the globe asking them about practices they follow for pandemic management, process re-engineering, lab safety measures, staff training, stress management, digitization, challenges related to resource allocation, remote reporting, and needs of leadership training.
She will also discuss her collaborative project with Koita Centre for Digital Health of IIT Bombay with Professor Biplab Banerjee on a risk prediction algorithm and model for COVID-19 using routine laboratory assay data.
“During this pandemic, we realized that the laboratory journey may not always come with a planner and roadmap,” Das said. “As unexpected and unprecedented health care needs push cost-burdens onto hospital systems, laboratories are faced with budget constraints while managing demand for higher quality and competitive turnaround time. Efficiently managing these intensifying pressures is critical to the sustainability of laboratory management and requires new strategies to reduce cost burden while maintaining quality.”
Laboratory medicine professionals have responded to the challenge with initiatives to harmonize reference intervals, action limits, critical result reporting, continuous quality improvement, inventory management, resource allocation, cost of ownership, deployment of automation, and implementation of digital technology transformation systems.
How labs are dealing with these challenges will be discussed during a Roundtable Session, Clinical Laboratory Leadership and Management During a Pandemic: A Global Perspective, on Tuesday, July 26 at the 2022 AACC Annual Scientific Meeting in Chicago. Barnali Das, MD, DNB, PGDHHM, a consultant in laboratory medicine for Kokilaben Dhirubhai Ambani Hospital in Mumbai, India, will explore effective leadership strategies for process re-engineering, time management, resource and personnel management, team development, strategic planning, global harmonization, and cost of ownership.
“In this pandemic, processes need to be streamlined in laboratory medicine to ensure provision of reliable and timely test results and appropriate alliance with brain-to-brain loops, thus enhancing quality of care and patient safety,” Das said, who is also chair of AACC’s India Local Section. “By adopting strategic thinking, embracing innovation, and investing in cross-training and safety measures, laboratory staff can contribute to patient satisfaction, reduced staff turnover, and improved laboratory performance. This contributes to successful operations and, at the same time, improves staff training, job satisfaction, and empowerment.”
Among the topics that will be covered in the session:
Harmonization and standardization of laboratory assays.
“What is considered the normal and acceptable range of different laboratory test results in a particular population have long been debated by experts, largely because levels of markers can change in relation to other biochemicals, biomolecules, and hormones, which themselves vary with race, age, different physiological conditions, and other illnesses and interfering substances,” Das said, who is also executive member of scientific division of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and has worked with different standardization committees of IFCC.
Total laboratory automation and artificial intelligence in routine laboratory testing.
Rapid changes in the diagnostic sector, coupled with advances in technology, have stimulated new approaches for laboratory automation and artificial intelligence in routine laboratory process flows. How are clinical laboratories across the globe employing these technologies to improve operations?
Leadership skills for effective laboratory management.
From team development to stress management to communication, laboratory leaders use various tools to ensure their teams are operating effectively. What are some successful techniques clinical laboratories in different parts of the world employ?
Cost of ownership.
Proper management of both direct and indirect costs is crucial to making operational improvements. Das will explore ways laboratorians can have a dramatic impact on performance using value stream maps.
She will also present results of a survey sent to lab leaders across the globe asking them about practices they follow for pandemic management, process re-engineering, lab safety measures, staff training, stress management, digitization, challenges related to resource allocation, remote reporting, and needs of leadership training.
She will also discuss her collaborative project with Koita Centre for Digital Health of IIT Bombay with Professor Biplab Banerjee on a risk prediction algorithm and model for COVID-19 using routine laboratory assay data.
“During this pandemic, we realized that the laboratory journey may not always come with a planner and roadmap,” Das said. “As unexpected and unprecedented health care needs push cost-burdens onto hospital systems, laboratories are faced with budget constraints while managing demand for higher quality and competitive turnaround time. Efficiently managing these intensifying pressures is critical to the sustainability of laboratory management and requires new strategies to reduce cost burden while maintaining quality.”
Latest AACC 2022 News
- AACC 2022 Review: International Meetings Rebound After Suffering Long COVID Hiatus
- Faster Method Diagnoses Pediatric Urinary Tract Infections
- Tianlong Showcases Integrated PCR Lab Solutions at AACC 2022
- Cellavision Introduces New Workflow Solution for Low-Volume Hematology Labs at AACC 2022
- Advanced Instruments Introduces New Automated Osmometer at AACC 2022
- Innovative Smartphone and AI-Based Tests Featured at AACC 2022
- New Tests Presented at AACC 2022 to Solve Challenges in Children's Healthcare
- 10-Minute Sepsis Risk Stratification Test Introduced at AACC 2022
- New System Combining DNA/RNA Extraction and Smart PCR Setup Launched at AACC 2022
- Novel Small Volume Blood Collection Device Launched at AACC 2022
- AACC Disruptive Technology Award Finalists Tackle Cancer, Women's Health, and STDs
- Meridian Demonstrates State-of-the-Art Urea Breath Test System at AACC 2022
- Nikon Instruments Displays Latest Clinical Pathology Products at AACC 2022
- Seegene Showcases Latest Molecular Testing Solutions at AACC 2022
- Werfen Introduces New Acute Care Diagnostic Products for CVOR at AACC 2022
- PerkinElmer Demonstrates Vanadis NIPT Screening Platform Featuring Groundbreaking cfDNA Technology
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







 Analyzer.jpg)
